[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 21, Issue 3 (Iranian South Medical Journal 2018) ::
Iran South Med J 2018, 21(3): 228-241 Back to browse issues page
Design, Synthesis and Radiolabeling of Peptide GPRPILE with 18FDG as Fibrin Imaging Agent for Thrombosis Detection
Sedegheh Rezaeianpour1 , Mona Mosayebnia2, Atefeh Hajiagha Bozorgi3, Abolghasem Moghimi1, Saeed Balalaie4, Soraya Shahhosseini 5
1- Department of chemistry, North Tehran Branch Islamic Azad University, Tehran, Iran
2- Department of Radiopharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
3- School of Pharmacy, Alborz University of Medical Sciences, Karaj, Iran
4- Peptide Chemistry Research Center, K.N. Toosi University of Technology
5- Department of Pharmaceutical Chemistry and Radiopharmacy, School of Pharmacy, Protein Technology Research Center, Shahid Behesti University of Medical Sciences, Tehran, Iran , s_shahoseini@sbmu.ac.ir
Abstract:   (2134 Views)
Background: The radionuclide of choice for routine clinical PET imaging is 18-F. As direct fluorination of peptides with 18-F is not possible, indirect methods using fluorinated prosthetic groups have been developed. Due to the availability of 18FDG in most PET centers, there is potential for 18FDG as a fluorinated prosthetic group. In this study, the linear peptide GPRPILE with an aminooxy group was designed, synthesized and radiolabeled with 18FDG as fibrin imaging agent.
Material and Methods: Docking studies were conducted done using AutoDock 4.1 and HEX software programs. Aoe-GPRPILE peptide was designed, synthesized through Fmoc method and radiolabeled with 18FDG. The radiochemical purity, stability of radiolabeled and cold peptide in PBS and human plasma was determined using chromatographic methods. The solubility ratio of the radiolabeled peptide in lipid to water (LogP) was determined.
Results: Docking and pharmacophore studies using HEX software revealed high affinity of designed peptide to fibrin (E Total=-0.01). The identity and structure of peptide were determined by LC-Mass. Peptide was stable over 24 hr in human plasma and PBS buffer. The optimum conditions of radiolabeling were 0.2 mg peptide, 1 mCi 18FDG, 90°C for 30 min, pH=5. The radiochemical purity was over 95%. The stability of radiolabeled peptide in human plasma for 2 hr was over 95%. The partition coefficient (LogP) was 1.5.
Conclusion: 18FDG has a high potential to be used as a prosthetic group for radiolabeling of peptides with 18-F. In this study, peptide Aoe-GPRPILE with aminooxy was synthesized and labeled with 18FDG with high yield and radiochemical purity. Aminooxy is conjugated to peptide sequence as a prosthetic group in the last step with minimal effect on peptide properties and selectively forms stable oxime bond with the aldehyde group of 18FDG.
Keywords: Thrombosis, Radiolabeling with 18FDG, Peptide, fibrin
Full-Text [PDF 1209 kb]   (975 Downloads)    
Type of Study: Original | Subject: Radiology. Diagnostic Imaging
Received: 2017/11/2 | Accepted: 2018/01/22 | Published: 2018/07/21
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rezaeianpour S, Mosayebnia M, Hajiagha Bozorgi A, Moghimi A, Balalaie S, Shahhosseini S. Design, Synthesis and Radiolabeling of Peptide GPRPILE with 18FDG as Fibrin Imaging Agent for Thrombosis Detection. Iran South Med J. 2018; 21 (3) :228-241
URL: http://ismj.bpums.ac.ir/article-1-930-en.html

Volume 21, Issue 3 (Iranian South Medical Journal 2018) Back to browse issues page
دانشگاه علوم پزشکی بوشهر، طب جنوب ISMJ

Iranian South Medical Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License which allows users to read,
copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly

Copyright © 2017, Iranian South Medical Journal| All Rights Reserved

Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 4256